Navigation Links
Blood Test May Catch Deadly Fungal Infection Quickly
Date:4/24/2013

By Amy Norton
HealthDay Reporter

WEDNESDAY, April 24 (HealthDay News) -- An experimental test could help doctors catch a deadly type of fungal infection in the blood within a few hours, rather than the few days it currently takes, a new study suggests.

The test, which is not yet on the market, looks for Candida infection in the blood. The fungus is best known for causing common vaginal yeast infections, but when it gets into the bloodstream it can cause serious infections of organs and tissue throughout the body.

Candida blood infections -- known as candidemia -- are very rare in healthy people, but they are the fourth most common type of blood infection among U.S. hospital patients, according to the U.S. Centers for Disease Control and Prevention.

The infection is typically transmitted through contaminated catheters, and seen in seriously ill patients -- such as those in the intensive care unit, or with weakened immune systems.

The symptoms of candidemia are vague, and include fever and chills, so doctors use blood cultures to diagnose it. That means putting a blood sample in a special broth that feeds the yeast organism until it grows enough to be detected.

But Candida "is a slow grower," and it takes a few days to get blood culture results back, said Thomas Lowery of T2 Biosystems, the Lexington, Mass.-based company developing the new test.

By that time, it may be too late for the patient. About 40 percent of people with Candida blood infections die, and delayed diagnosis bears part of the blame, Lowery and his colleagues write in the April 24 issue of the journal Science Translational Medicine.

Getting a precise diagnosis is vital, Lowery said, both to confirm that it's Candida, and to pinpoint which type it is. "You need to know the specific Candida so you can use the right antifungal drug," he said.

In the new study, Lowery's team found that the test they've developed can reliably detect the five most common species of Candida within about three hours.

The researchers used blood samples from healthy people and "spiked" them with Candida yeast. They then analyzed the samples with the new test and with standard blood cultures. The two tests were in agreement on "positives" 98 percent of the time.

An expert not involved in the research said the test's sensitivity is "very, very good."

"This is preliminary, but the technology looks extremely promising," said Christine Ginocchio, chief of infectious disease diagnostics at North Shore-LIJ Health System in Lake Success, N.Y.

What's particularly "exciting" is that the technology could potentially be used to test for other pathogens that cause serious bloodstream infections, according to Ginocchio, who is also a member of the Infectious Diseases Society of America's Diagnostics Task Force.

Ideally, Ginocchio explained, when doctors suspect a patient has a bloodstream infection, they would be able to take a blood sample, directly test it, then have a result in a few hours. The problem right now is that a blood sample would normally not contain enough of the culprit bug -- be it a fungus or bacterium -- to detect.

Plus, Ginocchio noted, the blood contains a lot of other genetic material that gets in the way of spotting that bit of foreign-invader DNA. That's why blood cultures are done.

The new test, which is based on so-called magnetic resonance technology, essentially removes the "noise" coming from other material in the blood sample, allowing it to zero in on the pathogen.

There is still more work to be done. "Now you'd like to see this tested in a larger, multicenter trial," Ginocchio said.

The process would also need to be automated, she noted, to be feasible for smaller community hospitals. T2 Biosystems' Lowery said the researchers are working on making the method "fully automated."

Exactly what it would all cost is not known. But both Ginocchio and Lowery said that if the test gets more patients on the right drug quickly, the cost would likely be worth it.

According to Lowery's team, research suggests that with Candida infections, starting the right antifungal drug within 12 hours can cut the death rate from 40 percent to 11 percent.

More information

Learn more about Candida blood infections from the U.S. Centers for Disease Control and Prevention.

SOURCES: Thomas Lowery, Ph.D., vice president, diagnostics research and development, T2 Biosystems, Lexington, Mass; Christine Ginocchio, Ph.D., chief, infectious disease diagnostics, North Shore-LIJ Health Systems Laboratories, Lake Success, N.Y.; April 24, 2013, Science Translational Medicine, online


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Off-the-Shelf Artificial Blood Vessels Show Promise
2. Exercise, Alternative Therapies May Help Lower Blood Pressure
3. Metastasis stem cells in the blood of breast cancer patients discovered
4. Tekturna Infographic Released by d’Oliveira & Associates Imparts Potential Side Effects of Blood Pressure Drug
5. Blood pressure out of control at safety-net clinics
6. Rockford Ravens Rugby Football Club to Host Blood Drive with Rock River Valley Blood Center
7. Increased risk of cardiovascular disease for pregnant women with high blood pressure
8. 2013 NuvaRing Blood-Clotting Allegations Inquiries Eligible for Review by Resource4thePeople Attorneys
9. Blood Drive at Crimson Pointe Assisted Living Facility with Rock River Valley Blood Center
10. Could Coffee Bean Extract Help Control Blood Sugar?
11. Blood tests can provide fuller picture of mutations in cancer than traditional biopsies do
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Test May Catch Deadly Fungal Infection Quickly
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: